Nurse Practitioner, Adult Health · Seattle, WA
NPI
1053772533
Since 2016
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
825 Eastlake Ave E
Seattle, WA, 98109
Phone (206) 288-1024
Groups this clinician bills Medicare through
Medicare paid, 2024
$22K
323 services
Medicare patients, 2024
110
Average age 71
Drug cost, 2024
$3.6M
764 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kathleen R Weaver was code 99214 (office e&m - established), 277 times for 103 patients. In total Kathleen R Weaver billed 323 services in 8 codes, and Medicare paid $22K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-03-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 277 | 103 | $70.50 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 14 | $12.44 | $274 |
By year: 2022 $25K for 356 services; 2023 $19K for 279 services; 2024 $22K for 323 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kathleen R Weaver prescribed most often to Medicare patients was Tagrisso (Osimertinib Mesylate), with 114 prescriptions and refills. In total Kathleen R Weaver wrote 764 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tagrisso Osimertinib Mesylate | 114 | 118 | 15 | $2.0M |
| Oxycodone Hcl Generic | 58 | 58 | 22 | $612 |
| Potassium Chloride Generic | 41 | 47 | 17 | $1,364 |
| Alecensa Alectinib Hcl | 41 | 41 | Under 11 | $674K |
| Eliquis Apixaban | 38 | 44 | Under 11 | $24K |
| Dexamethasone Generic | 28 | 37 | 19 | $271 |
| Ondansetron Hcl Generic | 25 | 25 | 17 | $197 |
| Levothyroxine Sodium Generic | 24 | 39 | 11 | $177 |
| Omeprazole Generic | 22 | 25 | Under 11 | $237 |
| Prochlorperazine Maleate Generic | 19 | 19 | 14 | $305 |
| Prednisone Generic | 19 | 22 | 12 | $105 |
| Gabapentin Generic | 18 | 18 | Under 11 | $134 |
| Xarelto Rivaroxaban | 17 | 32 | Under 11 | $17K |
| Triamcinolone Acetonide Generic | 13 | 15 | Under 11 | $83.69 |
| Lorbrena Lorlatinib | 13 | 13 | Under 11 | $285K |
Brand drugs: 301 claims; generic drugs: 463 claims; opioid claims: 89.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Kathleen R Weaver were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.